Tagged with Japan

Real-World Evidence Regulatory Landscape in Asia Pacific
Japan Healthcare and Pharma News: COVID-19 pill from Shionogi, Takeda’s bounce back from profit drop, Hitachi/Invivoscribe partnership …
Kirin’s $870 Million Pharma Investment & ‘Fermentation Biotech’ Transformation
Japan Pharma News: Kirin Looks Beyond Beer; Sanofi Rare Disease Approval; Japanese COVID Vaccines Incoming
Japan PMDA Drug Approvals 2021
Top 10 Global Pharma Markets Ranking
PMDA Chief Executive Yasuhiro Fujiwara on Regulatory Utilisation of RWD & RWE in Japan
The COVID-19 Pandemic in Japan: Treatments, Vaccines & Remote Study Audits
Takafumi Horii – SVP, Head of Japan Oncology Business Unit, Global Oncology Business Unit, Takeda
PharmaBoardroom’s Top 5 Op-Eds in 2021 (So Far)
Enhancing Patient Engagement in Clinical Trials in Japan
Japan Oncology Market Snapshot 2021
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here